Rofo 2018; 190(12): 1169-1170
DOI: 10.1055/a-0757-0094
Letter to the Editor
© Georg Thieme Verlag KG Stuttgart · New York

T2-weighted PROPELLER MRI is not suitable for pulmonary emphysema quantification

Authors

  • Ilyes Benlala

    Université de Bordeaux Collège Sciences de la Santé, Centre Hospitalier Universitaire de Bordeaux
  • François Laurent

    Université de Bordeaux Collège Sciences de la Santé, Centre Hospitalier Universitaire de Bordeaux
  • Gael Dournes

    Université de Bordeaux Collège Sciences de la Santé, Centre Hospitalier Universitaire de Bordeaux
Further Information

Publication History

Publication Date:
25 October 2018 (online)

Preview

To the Editor:

We read with interest the recent publication by Meier-Schroers M et al. [1] related to the Quantitative and Qualitative Assessment of Pulmonary Emphysema with T2-Weighted PROPELLER MRI in a High-Risk Population Compared to Low-Dose CT. Quantifying emphysema is a crucial issue for the phenotype and the follow-up of chronic obstructive pulmonary disease (COPD) patients who will need to undergo chest computed tomography (CT) scans periodically. Thus, lung magnetic resonance imaging (MRI) could be a non-ionizing noninvasive imaging alternative. However, due to low intrinsic proton density of the lung, cardio respiratory motion effects and a very short T2* caused by air-tissue interfaces, the parenchymal MR signal acquired using standard sequences is very low. In addition, emphysema characterized by tissue destruction, decreased perfusion and hyperinflation further reduces the parenchymal MRI signal.